Clinical Trials Browser

Terminated × Solid Tumors × pembrolizumab × Clear all

NCT05996445 2024-08-23

A Study of XmAb®662 as Monotherapy or in Combination With Pembrolizumab in Advanced Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Solid Tumors

NCT02587962 2021-01-14

Dose-escalation Study of Birinapant and Pembrolizumab in Solid Tumors

Phase 1/2 Terminated

34 enrolled 27 charts

Other solid neoplasm

Solid Tumors